Simple Summary Historically, cancers presenting with their main tumor mass in the ovary
have been classified as ovarian carcinomas (a concise term for epithelial ovarian cancer) …

Ovarian cancer typically presents at an advanced stage, and although the majority of cases
initially respond well to platinum-based therapies, chemoresistance almost always occurs …

Our objective was to test whether p53 expression status is associated with survival for
women diagnosed with the most common ovarian carcinoma histotypes (high‐grade serous …

Simple Summary Deleterious mutations in SWI/SNF chromatin remodeling genes, such as
ARID1A, are present in more than 50% of cases of ovarian clear cell carcinoma (OCCC), a …

The cellular origin of clear cell ovarian carcinoma (CCOC), a major histological subtype of
ovarian carcinoma remains elusive. Here, we explored the candidate cellular origin and …

Purpose: The purpose of this study was to evaluate RB1 expression and survival across
ovarian carcinoma histotypes and how co-occurrence of BRCA1 or BRCA2 (BRCA) …

Ovarian Clear Cell Carcinoma (OCCC) displays distinctive clinical and molecular
characteristics and confers the worst prognosis among all ovarian carcinoma histotypes …

Ovarian clear-cell cancer is a rare subtype of epithelial ovarian cancer with unique clinical
and biological features. Despite optimal cytoreductive surgery and platinum-based …

Objective Ovarian clear cell carcinoma (OCCC) is a subtype of epithelial ovarian carcinoma
with poor prognosis. However, no effective biomarkers have been established for predicting …

Chemotherapy plays an important role in controlling cancer progression, but the long-term
use of chemotherapeutic agents can lead to drug resistance and eventually treatment …